Pharma companies gain on defensive buying

Shares of Indian pharmaceutical companies perceived as defensive gain on risk aversion after overseas investors sold 2.67 billion rupees worth of Indian shares on Friday, extending their selling streak to a seventh day, provisional exchange data shows, dealers say.

"Stable cash flows and lower volatility of Indian pharma stocks are leading to some flows in the sector ahead of key events like Yellen's speech and inflation data," a dealer said.

Sun Pharmaceutical Industries Ltd gains 1.8 percent, Dr.Reddy's Laboratories Ltd is up 1.9 percent and Cipla Ltd is higher 1.2 percent.

Caution is also seen ahead of consumer price inflation and industrial output data due later in the week.

Post new comment

E-mail ID will not be published
CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.

EDITORIAL OF THE DAY

  • Amit Shah deserved to be crowned President of India, some say

    The Bharatiya Janata Party is now firmly in the hands of Modi’s alter ego, which in plain English means ‘another side of oneself, a second self’

FC NEWSLETTER

Stay informed on our latest news!

INTERVIEWS

GV Nageswara Rao

MD & CEO, IDBI Federal Life

Timothy Moe

Goldman Sachs

Chander Mohan Sethi

CMD, Reckitt Benckiser India

COLUMNIST

Arun Nigavekar

Necessary yet inadequate boost to education

The finance minister, in the very first minutes of his ...

Zehra Naqvi

We must overcome the fear of death

It is the biggest irony that the only thing that’s ...

Dharmendra Khandal

Jawai leopards and locals can coexist peacefully

At first glance, the Jawai landscape seems like a large ...

INTERVIEWS

William D. Green

Chairman & CEO, Accenture